Blog

(Washington Post via MSN) – Older adults — those 60 and older — are the fastest-growing group of cannabis users in the country. According to a 2022 study, adults over 60 who started using did so for medical reasons, including to treat pain and arthritis, sleep disturbances, anxiety and depression.

While more than three-quarters of those people found the cannabis either somewhat or very helpful, the question remains: What are the side effects? You may be particularly curious about brain effects, given concerns about cognitive decline. So what exactly does the research say? (Read More)

(NYT) – Plenty of people hate Mark Zuckerberg’s superintelligent, supercharged spectacles. I was ready to hate them, too.

Meta is investing heavily to promote its new product (a Super Bowl ad starring Spike Lee, a brick-and-mortar store on Fifth Avenue), which made me curious to take a peek through the eyes of the future. Yet A.I. glasses also feel so clearly unnecessary, so easily adaptable for malevolent ends. I was perfectly ready to hate them.

Instead, very quickly, I started to feel sorry for my sunglasses. They were like a kid who hasn’t done any of the reading but keeps being called on in class — and who also can’t make friends, because all of his classmates think he’s a spy. (Read More)

(WDKY Lexington via Yahoo!) – It’s now Kentucky law that if any medical provider observes any indication of life from the donor during organ harvesting, the procedure must stop.

House Bill 510 was signed into law on April 7, standardizing “pause in procedure” in the organ procurement process. The law was proposed after a Kentucky man’s organs were nearly harvested in 2021, while he was still alive. (Read More)

(WaPo) – The artificial intelligence company asked religious leaders for guidance on building a moral chatbot.

Anthropic, an artificial intelligence company valued at $380 billion, can take its pick of Silicon Valley talent thanks to the success of its chatbot, Claude. But last month, the start-up sought help from a group rarely consulted in tech circles: Christian religious leaders.

The company hosted about 15 Christian leaders from Catholic and Protestant churches, academia, and the business world at its headquarters in late March for a two-day summit that included discussion sessions and a private dinner with senior Anthropic researchers, according to four participants who spoke with The Washington Post. (Read More)

(WSJ) – We all took an oath to do no harm. That includes killing our patients.

Throughout medical school and residency, I always believed that people mattered. But it wasn’t until my conversion to Christianity that I understood why. Scripture teaches that people are made in God’s divine image. Medical schools don’t teach this moral reality, and therefore most medical schools no longer pledge to do no harm.

Instead, medical schools meticulously train physicians to look at patients only scientifically: knowledge through biochemistry, physics, anatomy, charts, machines, diagrams, lenses, statistical models, photographs, medical journals and pharmacology. In doing so, most doctors never learn to see the divine dignity of patients. (Read More)

(NYT) – China, the U.S., Russia and others have ramped up their contest over artificial-intelligence-backed weapons and military systems. The buildup has been compared to the dawn of the nuclear weapons age.

China’s military display and the U.S. countermove were part of an escalating global arms race over A.I.-backed autonomous weapons and defense systems. Designed to operate by themselves using A.I., the technology reduces the need for human intervention in decisions like when to hit a moving target or defend against an attack. (Read More)

(MIT Technology Review) – Companies are playing word games with promising cancer treatments.

In its formal communications, like regulatory filings, Moderna hasn’t called the shot a cancer vaccine since 2023. That’s when it partnered up with Merck and rebranded the tech as individualized neoantigen therapy, or INT. Moderna’s CEO said at the time that the renaming was to “better describe the goal of the program.” (BioNTech, the European vaccine maker that’s also working in cancer, has shifted its language too, moving from “neoantigen vaccine” in 2021 to “mRNA cancer immunotherapies” in its latest report.)

The logic of casting it as a therapy is that patients already have cancer—so it’s a treatment as opposed to a preventive measure. But it’s no secret what the other goal is: to distance important innovation from vaccine fearmongering, which has been inflamed by high-ranking US officials. (Read More)

(WSJ) – Jonathan Gavalas was a seemingly healthy and even-keeled 36-year-old when he began chatting with Gemini, Google’s chatbot, in part to seek comfort about splitting up with his wife.

A Wall Street Journal analysis of the entire chatlog between Aug. 25, 2025, and Oct. 2, 2025, covering more than 2,000 printed pages, shows that Gemini intervened at least 12 times to try to steer Gavalas back to reality and mentioned a crisis hotline seven times. The log also reveals that Gavalas was quickly able to direct Gemini right back into the fictional narrative, where it repeatedly encouraged his delusions.

Here are edited excerpts from those chats, which began rather mundane, turned increasingly strange, and ended up deadly. (Read More)